Antiparkinsonian medication masks motor signal progression in de novo patients

Antiparkinsonian medication masks motor signal progression in de novo patients

Patients not yet receiving medication provide insight to drug-naïve early physiology of Parkinson's Disease (PD). Wearable sensors can measure changes in motor features before and after introduction of antiparkinsonian medication. We aimed to identify features of upper limb bradykinesia, postur...

Full description

Bibliographic Details
Main Authors:	Maksymilian A. Brzezicki, Niall Conway, Charalampos Sotirakis, James J. FitzGerald, Chrystalina A. Antoniades
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Heliyon
Subjects:	Parkinson's Motor signal Medication Denovo Accelerometers
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023036228

Similar Items

Antiparkinsonian medication masks motor signal progression in de novo patients
by: Brzezicki, MA, et al.
Published: (2023)

Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning
by: Charalampos Sotirakis, et al.
Published: (2023-10-01)

Predicting future fallers in Parkinson’s disease using kinematic data over a period of 5 years
by: Charalampos Sotirakis, et al.
Published: (2024-12-01)

A Case of Pulmonary Artery thrombosis in situ: A Great Masquerade: Case Report
by: N. M. M. Risly, et al.
Published: (2025-01-01)

Identification of motor progression in Parkinson's disease using wearable sensors and machine learning
by: Sotirakis, C, et al.
Published: (2023)

Sensor-Based and Patient-Based Assessment of Daily-Living Physical Activity in People with Parkinson’s Disease: Do Motor Subtypes Play a Role?
by: Irina Galperin, et al.
Published: (2020-12-01)

Predicting future fallers in Parkinson’s disease using kinematic data over a period of 5 years
by: Sotirakis, C, et al.
Published: (2024)

Amantadine: an antiviral and antiparkinsonian agent
by: J. Staničová, et al.
Published: (2001-09-01)

Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures
by: Vladimir N. Fedorov, et al.
Published: (2024-12-01)

Efficacy of antiparkinsonian therapy in tremor correction according to tremorography
by: V. A. Bogacheva, et al.
Published: (2024-04-01)

PHARMACOKINETIC STUDIES OF NEW ANTIPARKINSONIAN DRUG RAPITALAM
by: Natalya Avdeeva, et al.
Published: (2016-12-01)

Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease
by: N. V. Titova, et al.
Published: (2021-03-01)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
by: Sara Silva, et al.
Published: (2021-04-01)

Drug utilization study of antiparkinsonian medication in Romania during 25 years
by: Camelia Bucsa, et al.
Published: (2025-02-01)

A Usability Pilot Study of a Sensor-Guided Interactive System for Dexterity Training in Parkinson’s Disease
by: Nic Krummenacher, et al.
Published: (2025-02-01)

The lipogenic enzyme acetoacetyl-CoA synthetase and ketone body utilization for denovo lipid synthesis, a review
by: James D. Bergstrom
Published: (2023-08-01)

Monogenic developmental and epileptic encephalopathies of infancy and childhood, a population cohort from Norway
by: Ida Stenshorne, et al.
Published: (2022-08-01)

Objectivization of efficiency of antiparkinsonian drug administration in correction of different types of tremor
by: D. V. Zakharov, et al.
Published: (2018-07-01)

Development of seven degree of freedom for ride analysis [electronic resource] /
by: 430921 Mohd. Shahrizam Dzolkefli
Published: (2007)

Development of seven degree of freedom for ride analysis /
by: 430921 Mohd. Shahrizam Dzolkefli, et al.
Published: (2007)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
by: Nicola Paccione, et al.
Published: (2022-12-01)

The Role of Paracetamol (acetaminophen) in the Reduction of Tremor in Parkinson’s Disease – a Case Study
by: Gary Marsden Golding
Published: (2020-04-01)

The comparative analysis of antiparkinsonian activity of glycine combined with amantadine in conditions of changing neurosynaptic transmission.
by: V. I. Mamchur, et al.
Published: (2017-10-01)

A New Wrist-Worn Tool Supporting the Diagnosis of Parkinsonian Motor Syndromes
by: Luigi Battista, et al.
Published: (2024-03-01)

Association between Physical Activity and Motor Proficiency among Primary School Children
by: Amir Dana, et al.
Published: (2023-07-01)

Investigation of antiparkinsonian activity of new imidazole-4,5-dicarboxylic acid derivatives on the experimental model of catalepsy
by: Vladimir D. Dergachev, et al.
Published: (2023-03-01)

Impact of Duration of Parkinsonism and Antiparkinsonian Drugs on Coagulation Parameters in Patients with Parkinson’s Disease
by: Varun Kodam, et al.
Published: (2024-10-01)

DIAGNOSIS OF BRAKE SYSTEMS OF MOTOR VEHICLES IN OPERATING CONDITIONS
by: Rasul V. Huseynov, et al.
Published: (2022-03-01)

Inertial Sensing to Determine Movement Disorder Motion Present before and after Treatment
by: Naser El-Sheimy, et al.
Published: (2012-03-01)

Real-Time Gait Cycle Parameter Recognition Using a Wearable Accelerometry System
by: Jun-Ming Lu, et al.
Published: (2011-07-01)

1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
by: Ana Ortíz de Zárate, et al.
Published: (2021-10-01)

A novel machine learning based framework for developing composite digital biomarkers of disease progression
by: Song Zhai, et al.
Published: (2025-01-01)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
by: Massimo Filippi, et al.
Published: (2023-09-01)

Relation of Apathy to Motor and Non-motor Findings in Parkinson’s Disease
by: Melek Gürbüz, et al.
Published: (2019-06-01)

Time-resolved quantification of fine hand movements as a proxy for evaluating bradykinesia-induced motor dysfunction
by: Rachel K. Spooner, et al.
Published: (2024-03-01)

Antiparkinsonian activity of new N-methyl-D-aspartate receptor ligands in the arecoline hyperkinesis test
by: V. D. Dergachev, et al.
Published: (2021-09-01)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
by: Yan Qu, et al.
Published: (2023-08-01)

Associations between device-measured physical activity and balance performance in children: Mediating role of motor self-efficacy
by: Baniasadi Tayebeh, et al.
Published: (2022-01-01)

Longitudinal monitoring of progressive supranuclear palsy using body-worn movement sensors
by: Sotirakis, C, et al.
Published: (2022)

Infant gross motor development and childhood physical activity: Role of adiposity
by: Tomoko Aoyama, et al.
Published: (2023-01-01)